BRPI0513095A - glicosìdeos polissulfatados e sais dos mesmos - Google Patents

glicosìdeos polissulfatados e sais dos mesmos

Info

Publication number
BRPI0513095A
BRPI0513095A BRPI0513095-6A BRPI0513095A BRPI0513095A BR PI0513095 A BRPI0513095 A BR PI0513095A BR PI0513095 A BRPI0513095 A BR PI0513095A BR PI0513095 A BRPI0513095 A BR PI0513095A
Authority
BR
Brazil
Prior art keywords
salts
polysulfated glycosides
polysulfated
glycosides
asthma
Prior art date
Application number
BRPI0513095-6A
Other languages
English (en)
Inventor
Janos Kuszmann
Istvan Kurucz
Gabor Medgyes
Nicholas Bodor
Original Assignee
Ivax Drug Res Inst Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Drug Res Inst Ltd filed Critical Ivax Drug Res Inst Ltd
Publication of BRPI0513095A publication Critical patent/BRPI0513095A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

GLICOSìDEOS POLISSULFATADOS E SAIS DOS MESMOS. A presente invenção refere-se aos glicosídeos polissulfatados da fórmula (I), os sais farmaceuticamente aceitáveis destes, como também as composições farmacêuticas contendo estes compostos como ingredientes ativos. Além disso a invenção fornece um método de impedir, tratar ou aliviar os sintomas de distúrbios inflamatórios agudos e crónicos das vias aéreas de mamíferos - incluindo asma e patologias relacionadas à asma.
BRPI0513095-6A 2004-08-05 2005-08-05 glicosìdeos polissulfatados e sais dos mesmos BRPI0513095A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59914804P 2004-08-05 2004-08-05
PCT/US2005/027877 WO2006017726A2 (en) 2004-08-05 2005-08-05 Polysulfated glycosides and salts thereof

Publications (1)

Publication Number Publication Date
BRPI0513095A true BRPI0513095A (pt) 2008-03-11

Family

ID=35781354

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513095-6A BRPI0513095A (pt) 2004-08-05 2005-08-05 glicosìdeos polissulfatados e sais dos mesmos

Country Status (25)

Country Link
US (2) US7902158B2 (pt)
EP (1) EP1778709B1 (pt)
JP (1) JP5164572B2 (pt)
KR (1) KR101097702B1 (pt)
CN (1) CN101014607B (pt)
AT (1) ATE397006T1 (pt)
AU (1) AU2005271349B2 (pt)
BR (1) BRPI0513095A (pt)
CA (1) CA2576131C (pt)
CY (1) CY1108900T1 (pt)
DE (1) DE602005007244D1 (pt)
DK (1) DK1778709T3 (pt)
ES (1) ES2308536T3 (pt)
HK (1) HK1098758A1 (pt)
IL (1) IL181095A (pt)
MX (1) MX2007001444A (pt)
NO (1) NO20070987L (pt)
NZ (1) NZ553292A (pt)
PL (1) PL1778709T3 (pt)
PT (1) PT1778709E (pt)
RU (1) RU2413734C2 (pt)
SI (1) SI1778709T1 (pt)
UA (1) UA87154C2 (pt)
WO (1) WO2006017726A2 (pt)
ZA (1) ZA200700758B (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1778709T1 (sl) 2004-08-05 2008-12-31 Ivax Drug Res Inst Ltd Polisulfatirani glikozidi in njihove soli
WO2010037180A1 (en) * 2008-10-03 2010-04-08 Glycan Biosciences Pty Ltd Anionic oligosaccharide conjugates
RU2519781C2 (ru) * 2009-02-02 2014-06-20 Оцука Кемикал Ко., Лтд. Низкомолекулярное полисульфатированное производное гиалуроновой кислоты и содержащее его лекарственное средство
PL399450A1 (pl) * 2009-08-31 2013-01-21 Depomed, Inc Utrzymujace sie w zoladku kompozycje farmaceutyczne do natychmiastowego i przedluzonego uwalniania acetaminofenu
MX2012006265A (es) 2009-12-03 2012-07-25 Opko Health Inc Formulaciones disacaridas hipersulfatadas.
US20130203695A1 (en) * 2010-10-29 2013-08-08 Opko Health, Inc. Hypersulfated disaccharides to treat elastase related disorders
WO2012058719A1 (en) * 2010-11-02 2012-05-10 The Universtity Of Sydney Inhalable compositions
PT3274347T (pt) * 2015-03-26 2020-10-01 Giuliani Spa Compostos tendo atividade antioxidante contra radicais livres e atividade anti-inflamatória, e correspondentes composições farmacêuticas para o cuidado da pele
WO2018035050A1 (en) 2016-08-16 2018-02-22 Opko Pharmaceuticals, Llc Pure heptasulfated disaccharides having improved oral bioavailability
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
WO2018043666A1 (ja) 2016-08-31 2018-03-08 王子ホールディングス株式会社 酸性キシロオリゴ糖の製造方法
JP6281659B1 (ja) * 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
SG11201911318SA (en) 2017-05-31 2020-01-30 Oji Holdings Corp Moisturizing topical preparation
BR112020004787A2 (pt) 2017-09-12 2020-09-24 Oji Holdings Corporation polissulfato de pentosano, composição farmacêutica, anticoagulante, e, método para produzir polissulfato de pentosano
PL3730521T3 (pl) 2017-12-20 2023-10-09 Oji Holdings Corporation Polisiarczan pentozanu i lek zawierający polisiarczan pentozanu

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4021544A (en) * 1976-07-12 1977-05-03 American Cyanamid Company Complement inhibitors
DE3734815A1 (de) * 1987-10-14 1989-04-27 Luitpold Werk Chem Pharm Polyschwefelsaeureester von bis-aldonsaeureamiden und deren derivaten, verfahren zu ihrer herstellung und arzneimittel
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
US5380716A (en) * 1988-12-15 1995-01-10 Glycomed, Inc. Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
JPH05164572A (ja) 1991-12-12 1993-06-29 Y E Data Inc エンコーダ
DE69316754T2 (de) * 1992-06-01 1998-07-16 Biomembrane Inst Schrittweise entfernung von monosacchariden vom reduzierenden ende von oligosacchariden und verwendungen davon
DE4408248A1 (de) * 1994-03-11 1995-09-14 Hoechst Ag Physiologisch verträgliche und physiologisch abbaubare Kohlenhydrat-Mimetika, ein Verfahren zur Herstellung und ihre Verwendung
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
JPH08109134A (ja) * 1994-10-11 1996-04-30 Sanwa Kagaku Kenkyusho Co Ltd 細胞変成抑制並びに臓器毒性軽減剤
US6153736A (en) * 1995-09-27 2000-11-28 The Liposome Company, Inc. Modified ether glyceroglycolipids
JPH09183789A (ja) 1995-10-31 1997-07-15 Sanwa Kagaku Kenkyusho Co Ltd 新規な硫酸化及び燐酸化糖誘導体、その製法及び用途
AU5706699A (en) * 1998-11-24 2000-06-13 American Home Products Corporation Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
JP4913272B2 (ja) 1999-01-07 2012-04-11 生化学工業株式会社 オリゴ糖の製造方法ならびに新規オリゴ糖およびそれを含む医薬組成物
WO2002083700A2 (en) * 2001-04-16 2002-10-24 Ivax Research, Inc. Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
BR0311645A (pt) * 2002-06-07 2005-02-22 Dzucker Ag Mannheim Ochsenfurt Isomalte de galactosila - procedimento para sua produção e emprego
SI1778709T1 (sl) 2004-08-05 2008-12-31 Ivax Drug Res Inst Ltd Polisulfatirani glikozidi in njihove soli
SE535900C2 (sv) 2008-10-16 2013-02-12 Rolls Royce Ab Anordning för propellerpitchstyrning

Also Published As

Publication number Publication date
WO2006017726A2 (en) 2006-02-16
ATE397006T1 (de) 2008-06-15
NO20070987L (no) 2007-04-11
AU2005271349A1 (en) 2006-02-16
IL181095A (en) 2013-07-31
IL181095A0 (en) 2007-07-04
ZA200700758B (en) 2008-08-27
KR101097702B1 (ko) 2011-12-22
US20110118198A1 (en) 2011-05-19
AU2005271349B2 (en) 2011-10-27
DE602005007244D1 (de) 2008-07-10
MX2007001444A (es) 2007-07-04
RU2007107935A (ru) 2008-09-10
SI1778709T1 (sl) 2008-12-31
US20070281893A1 (en) 2007-12-06
DK1778709T3 (da) 2008-09-22
RU2413734C2 (ru) 2011-03-10
NZ553292A (en) 2009-06-26
EP1778709A2 (en) 2007-05-02
CA2576131C (en) 2012-04-24
HK1098758A1 (en) 2007-07-27
CN101014607A (zh) 2007-08-08
UA87154C2 (uk) 2009-06-25
CA2576131A1 (en) 2006-02-16
KR20070042188A (ko) 2007-04-20
WO2006017726A3 (en) 2006-04-20
US7902158B2 (en) 2011-03-08
JP2008509156A (ja) 2008-03-27
CY1108900T1 (el) 2014-07-02
CN101014607B (zh) 2014-05-14
PT1778709E (pt) 2008-07-24
EP1778709B1 (en) 2008-05-28
JP5164572B2 (ja) 2013-03-21
PL1778709T3 (pl) 2008-10-31
ES2308536T3 (es) 2008-12-01
US8987216B2 (en) 2015-03-24

Similar Documents

Publication Publication Date Title
BRPI0513095A (pt) glicosìdeos polissulfatados e sais dos mesmos
NO20025601D0 (no) Arylmetylaminderivater for anvendelse som tryptaseinhibitorer
EA200900613A1 (ru) Спирокетоновые ингибиторы ацетил-коа-карбоксилаз
EA200702339A1 (ru) Замещенные амидные производные в качестве ингибиторов протеинкиназы
ATE442349T1 (de) Diacylglycerol-acyltransferase-hemmer
NO20061254L (no) Farmasoytiske blandinger
MX2012000488A (es) Terapia de combinacion para el tratamiento de la diabetes.
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
NO20082000L (no) Pyrimidinamidforbindelser som PGDS-inhibitorer
GB0625648D0 (en) Compounds
BRPI0507189A (pt) uso combinado de um agonista de glp-1 e compostos de gastrina
EA200970435A1 (ru) Лечение общих расстройств развития
ATE524450T1 (de) 5-phenyl-isoxazol-3-carboxamid-derivate als trpv1-modulatoren
WO2007143557A3 (en) Compounds and methods for treating mammalian gastrointestinal parasitic infections
DK1296972T3 (da) Arylmethylamin-derivater til anvendelse som tryptaseinhibitorer
NO20065256L (no) Arylfenylamino-, arylfenylamid- og arylfenyleter-sulfidderivater
WO2006017752A8 (en) Sulfated oligosaccharides
IS2575B (is) Ný samverkandi samsetning sem felur í sér róflúmílast og formóteról
WO2005105766A3 (en) Arylphenylamino-and arylphenylether-sulfide derivatives, useful for the treatment of inflammatory and immune diseases, and pharmaceutical compositions containing them
MA27538A1 (fr) Combinaison synergique comprenant du roflumilast et du (r,r)-formoterol
WO2006017727A3 (en) Glycosides and salts thereof
NO20082656L (no) N-sulfamoyl-N'-benzopyranpiperidiner som inhibitorer av karbonsyreanhydraser
TW200500347A (en) Novel substituted 2,3-benzodiazepine derivatives
WO2008022242A3 (en) Synthesis of propyl phenoxy ethers and use as delivery agents
BRPI0516457A (pt) uso de um composto, e, composição farmacêutica para a administração pulmonar do composto ou de um sal farmaceuticamente aceitável, de uma pró-droga ou de um solvato do mesmo

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]